Detalhe da pesquisa
1.
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
J Formos Med Assoc
; 120(3): 956-964, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077341
2.
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study.
J Infect Dis
; 218(7): 1075-1084, 2018 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741704
3.
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.
J Formos Med Assoc
; 117(7): 588-597, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29456079
4.
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).
J Hepatol
; 64(5): 1011-1019, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26739688
5.
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
Hepatology
; 62(4): 1013-23, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26118427
6.
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy.
J Hepatol
; 62(1): 41-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25152207
7.
Association of MRC-1 and IL-28B with the treatment outcome of hepatitis C: a case control study.
BMC Gastroenterol
; 14: 113, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24969847
8.
The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese.
BMC Immunol
; 14: 21, 2013 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23651608
9.
Genetic variation in NOS2A is associated with a sustained virological response to peginterferon plus ribavirin therapy for chronic hepatitis C in Taiwanese Chinese.
J Med Virol
; 85(7): 1206-14, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23918539
10.
Association of genetic variations in GNB1 with response to peginterferon plus ribavirin therapy for chronic hepatitis C in a Chinese population in Taiwan.
BMC Gastroenterol
; 12: 167, 2012 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23171003
11.
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
Sci Rep
; 10(1): 5372, 2020 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32214132
12.
Persistent transaminase elevations in chronic hepatitis C patients with virological response during peginterferon and ribavirin therapy.
Hepatogastroenterology
; 56(91-92): 798-801, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19621705
13.
Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.
Antivir Ther
; 24(2): 133-140, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865588
14.
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.
Clin Cancer Res
; 24(1): 73-83, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018051
15.
Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C.
PLoS One
; 11(8): e0160450, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27505293
16.
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
PLoS One
; 10(4): e0122259, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25835020
17.
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.
PLoS One
; 10(9): e0137852, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368130
18.
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse.
J Interferon Cytokine Res
; 34(3): 187-94, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24237300
19.
Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes.
Aliment Pharmacol Ther
; 48(8): 875-876, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281835